First step to curb COVID vaccine misinformation is finding out who is most vulnerable
The success of Australia’s COVID-19 vaccine rollout will depend on everyone’s willingness to receive it. But experts have warned vaccine misinformation online puts Australia’s communities at risk...
It will be a long, long wait for Covid herd immunity
Opinion: The ongoing crisis over the Covid-positive person who visited Wellington from Sydney raises questions about the Government’s zero Covid stance, writes Professor Ananish Chaudhuri.
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.
Recruitment commences for Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines
Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines.
Surgical masks as good as N95 masks for health-care workers providing routine COVID-19 care
Surgical masks are not inferior to N95 masks for preventing the spread of COVID-19 to health-care workers, says a study led by McMaster University researchers.
Religious people coped better with Covid-19 pandemic, research suggests
Two Cambridge-led studies suggest that the psychological distress caused by lockdowns (UK) and experience of infection (US) was reduced among those of faith compared to non-religious people.
Anhalt University will continuing to retain admission and enrollment for international students
Mister Dornberger, Anhalt University is one of the most international universities in Germany. Over 36 percent of our students come from another country.
Belgian COVID-19 patient re-infected only three months after the initial infection
A Belgian patient had COVID-19 twice. She was reinfected 93 days after the first infection and experienced symptoms in both occasions.
High blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus...
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest...
Funding boost to improve manufacturing of viral vaccines
OVO Biomanufacturing, a spin-out company from Coventry University and the University of Warwick, has successfully secured £100,000...
- Advertisement -
